Flagship Ventures Fund IV-Rx, L.P., 10% Owner at Evelo Biosciences, Inc. (EVLO), bought 6,666,666 shares at $3.75 ($25.0M) on 2020-06-29, disclosed to the SEC on 2020-07-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 333,333 | $1.2M | 5.0% |
| 2 | $3.75 | 333,333 | $1.2M | 5.0% |
| 3 | $3.75 | 1,333,333 | $5.0M | 20.0% |
| 4 | $3.75 | 1,333,333 | $5.0M | 20.0% |
| 5 | $3.75 | 1,666,667 | $6.3M | 25.0% |
| 6 | $3.75 | 1,666,667 |
| $6.3M |
| 25.0% |
| Total | $3.75 avg | 6,666,666 | $25.0M | 100% |
| Filing → |